Oral Presentation

[27PS3-am] Vaccines and bioactive agents

Mon. Mar 27, 2023 11:10 AM - 12:10 PM [Room PS3] (2F)

Chair: Naoki Takemura, Tetsuo Koshizuka

+Add all to schedule

11:10 AM - 11:22 AM

[27PS3-am01S] Development of a whole-virion inactivated vaccine against enterovirus D68

○Kota Senpuku^1,2, Chikako Nakamura³, Yuta Kunishima³, Toshiro Hirai^1,2,4, Yasuo Yoshioka^{1,2,3,4,5,6,7} (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. RIMD, Osaka Univ., 3. BIKEN, 4. OTRI, Osaka Univ., 5. MEI, Osaka Univ., 6. CiDER, Osaka Univ., 7. CAMaD, Osaka Univ.)

11:22 AM - 11:34 AM

[27PS3-am02] Mucosal Protection against Pathogens with Injectable Vaccines.

○ASUMI KANDA¹, NAGISA NAKATA¹, RYOTAROU MITSUMATA¹ (1. Vaccine & Biomedicine Dept. Denka Co., Ltd.)

11:34 AM - 11:46 AM

[27PS3-am03] Adjuvanted Norovirus Vaccine

○Nagisa Nakata¹, Takenori Oikawa¹, Tomohiro Narahara¹, Ryotarou Mitsumata¹ (1. Denka Co., Ltd.)

11:46 AM - 11:58 AM

[27PS3-am04] Plant-derived Lactobacillus paracasei IJH-SONE68 improves chronic allergy status and hepatic parameters: a randomized, double-blind, placebo-controlled clinical trial

○Masafumi Noda¹, Narandalai Danshiitsoodo¹, Keishi Kanno², Masanori Sugiyama¹ (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2. Hiroshima Univ. Hospital)

11:58 AM - 12:10 PM

[27PS3-am05] Identification of avian miRNAs involved in fever activity of inactivated whole influenza vaccine.

○Takuma Gotanda¹, Naoki Kishimoto², Nobutoki Takamune², Ryotarou Mitsumata¹, Shogo Misumi² (1. Denka Co., Ltd., 2. Kumamoto Univ.)

Session information